248 related articles for article (PubMed ID: 12219613)
1. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
[No Abstract] [Full Text] [Related]
2. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
3. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
4. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
5. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
6. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
7. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
Maetzel A; Krahn M; Naglie G
Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib for rheumatoid arthritis.
Megeff CE; Strayer SM
J Fam Pract; 2000 Feb; 49(2):108-9. PubMed ID: 10718683
[No Abstract] [Full Text] [Related]
9. [Celebrex: confirmed effectiveness and safety (new data)].
Nasonov EL
Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
[No Abstract] [Full Text] [Related]
10. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
11. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
Hochberg MC
Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
[TBL] [Abstract][Full Text] [Related]
12. [Symptomatic therapy of arthrosis and rheumatoid arthritis. Who will benefit from Coxib?].
MMW Fortschr Med; 2002 Apr; 144(14):53. PubMed ID: 12014284
[No Abstract] [Full Text] [Related]
13. Celecoxib for arthritis.
Med Lett Drugs Ther; 1999 Jan; 41(1045):11-2. PubMed ID: 9949762
[No Abstract] [Full Text] [Related]
14. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
15. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
16. [Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis. Results of a post-marketing surveillance].
Wigand R; Wehling M; Brauer HG; Stridde E; Vergin H; May M
Dtsch Med Wochenschr; 2004 May; 129(21):1188-92. PubMed ID: 15160322
[TBL] [Abstract][Full Text] [Related]
17. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
18. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
[No Abstract] [Full Text] [Related]
19. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
Håkansson J
Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
[No Abstract] [Full Text] [Related]
20. [COX-2 inhibitors: a new treatment in rheumatic diseases].
Puddu G; Cravero E
Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
